 |
|
Polio outbreak from oral vaccine identified - and controlled - in China
August 16, 2006A 2004 outbreak of polio in China traced back to live attenuated oral polio vaccine (OPV), which is widely used in global eradication efforts, highlights the small but significant risk to eradication posed by the use of OPV at suboptimal rates of coverage. The study, reported in the Sept. 1 issue of The Journal of Infectious Diseases, and now available online, describes the first outbreak of poliomyelitis in China in more than a decade and the first in that country caused by vaccine-derived virus.
This marks the fifth outbreak of vaccine-derived poliomyelitis reported in the world since 2000, the year in which China was certified free of wild-type poliovirus.
The study was conducted in 2004 by Jingjin Yu, MD, and colleagues in Beijing and elsewhere, involving virus isolated from an outbreak in Guizhou province in rural China. Reported national immunization coverage in China is close to 90 percent, but children in the affected area of Guizhou, the poorest province in China, had much lower rates of immunization at the time of the study: only 72 percent of one- to three-year-olds had received at least three doses of the oral vaccine.
The investigators identified six children (three cases and three contacts) in two small towns who had had acute and residual polio-like paralysis and from whom the same type of vaccine-derived poliovirus (type 1) was isolated. A seventh child with paralysis was negative for type 1 virus, but it was found in a close contact of that child. None of the children had been immunized against polio.
Based on the virus strain's known rates of mutation, the finding indicated that the isolates had been circulating for less than a year. This is in contrast to past experience with vaccine-derived strains, which have tended to persist for several years-suggesting how quickly this strain can revert to a paralytic and transmissible form.
Once the outbreak was identified, a province-wide immunization campaign was mounted targeting all children under age 5, with reported coverage of more than 90 percent. To date, the outbreak strain has not been found in any child with polio-like paralysis in the province or elsewhere in China.
In an accompanying editorial, Walter Dowdle, PhD, of the Task Force for Child Survival and Development and Olen Kew, PhD, of the Centers for Disease Control and Prevention, suggest that the China outbreak indicates that vaccine-derived poliovirus can emerge within pockets of lower OPV coverage in countries with overall high levels of immunization and disease surveillance, and that the virus can be contained if identified quickly. They also emphasize the importance of paying close attention to regions that have historically acted as reservoirs of polio, despite the fact that such remote communities as Guizhou were long thought to be unlikely sites for the re-emergence of the virus after eradication because of a lower frequency of exposure.
According to Dowdle and Kew, important questions about the use of oral polio vaccine arise from this outbreak. In 2003, the World Health Organization recommended discontinuing the use of live virus vaccine after the eradication of the disease and containment of poliovirus stocks. But the cost of switching entirely to inactivated polio vaccine would present financial challenges to poor nations, as the cost of the inactivated preparation is estimated at $2.00 to $3.00 per dose, in contrast to 3 cents per dose for the live attenuated oral vaccine. As Yu and colleagues point out, immunization policies will have to be carefully considered in light of both medical and financial concerns.
Infectious Diseases Society of America
The investigators identified six children (three cases and three contacts) in two small towns who had had acute and residual polio-like paralysis and from whom the same type of vaccine-derived poliovirus (type 1) was isolated. A seventh child with paralysis was negative for type 1 virus, but it was found in a close contact of that child. None of the children had been immunized against polio.
Based on the virus strain's known rates of mutation, the finding indicated that the isolates had been circulating for less than a year. This is in contrast to past experience with vaccine-derived strains, which have tended to persist for several years-suggesting how quickly this strain can revert to a paralytic and transmissible form.
Once the outbreak was identified, a province-wide immunization campaign was mounted targeting all children under age 5, with reported coverage of more than 90 percent. To date, the outbreak strain has not been found in any child with polio-like paralysis in the province or elsewhere in China.
In an accompanying editorial, Walter Dowdle, PhD, of the Task Force for Child Survival and Development and Olen Kew, PhD, of the Centers for Disease Control and Prevention, suggest that the China outbreak indicates that vaccine-derived poliovirus can emerge within pockets of lower OPV coverage in countries with overall high levels of immunization and disease surveillance, and that the virus can be contained if identified quickly. They also emphasize the importance of paying close attention to regions that have historically acted as reservoirs of polio, despite the fact that such remote communities as Guizhou were long thought to be unlikely sites for the re-emergence of the virus after eradication because of a lower frequency of exposure.
According to Dowdle and Kew, important questions about the use of oral polio vaccine arise from this outbreak. In 2003, the World Health Organization recommended discontinuing the use of live virus vaccine after the eradication of the disease and containment of poliovirus stocks. But the cost of switching entirely to inactivated polio vaccine would present financial challenges to poor nations, as the cost of the inactivated preparation is estimated at $2.00 to $3.00 per dose, in contrast to 3 cents per dose for the live attenuated oral vaccine. As Yu and colleagues point out, immunization policies will have to be carefully considered in light of both medical and financial concerns.
Infectious Diseases Society of America
Polio Current Events and Polio News RSSUNC researchers decode structure of an entire HIV genome
The structure of an entire HIV genome has been decoded for the first time by researchers at the University of North Carolina at Chapel Hill.
First genetically-engineered malaria vaccine to enter human trials
Walter and Eliza Hall Institute scientists have created a weakened strain of the malaria parasite that will be used as a live vaccine against the disease.
Eliminating polio requires global, coordinated effort -- Health Affairs article highlights risks, rewards of eradication
Eliminating polio everywhere will require global cooperation on several fronts, including lowering the cost for poor countries to vaccinate with inactivated polio vaccine (IPV), says a leading global health researcher in the July/August Health Affairs thematic issue on global health.
Parents of internationally adopted children advised to verify children's immunization levels
A study by the division of global child health at Case Western Reserve University School of Medicine cautions adoptive parents not to rely solely on vaccination records when gauging their internationally adopted children's immunizations.
Virginia Tech virologist developing more potent vaccine technology
Virginia Tech virologist Chris Roberts' goal is to develop a platform for a flu vaccine that allows rapid modifications to meet new strains of flu.
Catching the common cold virus: BYU researchers coming down with the rhinovirus genome
A new study by Brigham Young University researchers on the virus behind nearly half of all cold infections explains how and where evolution occurs in the rhinovirus genome and what this means for possible vaccines.
Mathematical models of adaptive immunity
More than five million people die every year from infectious diseases, despite the availability of numerous antibiotics and vaccines.
First Holistic Guide to Primate Disease Covers Critical Gap in Global Health
Why are so many infectious diseases jumping from animals to humans? Why do we have so little capacity to predict epidemics, or avoid them?
Most vaccine-allergic children can still be safely vaccinated, Hopkins experts say
With close monitoring and a few standard precautions, nearly all children with known or suspected vaccine allergies can be safely immunized, according to a team of vaccine safety experts led by the Johns Hopkins Children's Center.
Parents follow pediatrician advice on administering MMR vaccinations
News stories about an allegedly harmful link between the mumps, measles and rubella vaccine and the onset of autism had little effect on whether U.S. parents immunized their children, according to a review of immunization records and news stories. Parents' decisions were more likely influenced by recommendations from their child's pediatrician, the researchers said.
More Polio Current Events and Polio News Articles
 |
Polio: An American Story by David M. Oshinsky (Author) Here David Oshinsky tells the gripping story of the polio terror and of the intense effort to find a cure, from the March of Dimes to the discovery of the Salk and Sabin vaccines--and beyond. Drawing on newly available papers of Jonas Salk, Albert Sabin and other key players, Oshinsky paints a suspenseful portrait of the race for the cure, weaving a dramatic tale centered on the furious rivalry between Salk and Sabin. He also tells the story of Isabel Morgan, perhaps the most talented of all polio researchers, who might have beaten Salk to the prize if she had not retired to raise a family. Oshinsky offers an insightful look at the National Foundation for Infantile Paralysis, which was founded in the 1930s by FDR and Basil O'Connor, it revolutionized fundraising and the perception... |
 |
Small Steps: The Year I Got Polio by Peg Kehret (Author) Ten years ago, In a riveting story of courage and hope, Peg Kehret wrote of months spent in a hospital when she was twelve, first struggling to survive a severe case of polio, then slowly learning to walk again. The book deeply touched readers of all ages and received many awards and honors. This anniversary edition includes an updated and extended epilogue about the author's experiences since the original publication. It also includes twelve pages of new photos and a lengthy section about polio, past and present. This 10th Anniversary Edition will inspire a whole new generation of readers. Those readers who already love it will find themselves reaching for it one more time. |
 |
American Experience: The Polio Crusade Based in part on David Oshinsky's Pulitzer Prize-winning book, Polio: An American Story, this one-hour film chronicles a decades-long crusade, fueled by the bold leadership of a single philanthropy and its innovative public relations campaign, and features a bitter battle between two scientists and the breakthrough of a forgotten woman researcher. |
 |
The Polio Paradox: Understanding and Treating "Post-Polio Syndrome" and Chronic Fatigue by Richard L. Bruno (Author) Polio is a disease of paradoxes, the major one being that although the threat of the 'dreaded disease' ended with the Salk vaccine in 1954, many polio survivors are now experiencing the onset of 'Post-Polio Syndrome' (PPS), new but related symptoms which may include chronic fatigue, muscle weakness, intolerance to cold, and more. In his groundbreaking book, Dr. Bruno has sounded an alarming wake-up call for both doctors and PPS sufferers, including a large number who were originally misdiagnosed with something other than polio and can now pursue the medical help they need. By revealing how the treatment of polio in the past has exacerbated what we now call PPS today, THEPOLIO PARADOX provides hope and new treatment information for an entire generation. |
 |
Living with Polio: The Epidemic and Its Survivors by Daniel J. Wilson (Author) Polio was the most dreaded disease of twentieth-century America. Whenever and wherever it struck, hospitals filled with victims of the virus. Many experienced only temporary paralysis, but others faced a lifetime of disability. Living with Polio is the first book to focus primarily on the personal stories of the men and women who had acute polio and lived with its crippling consequences. |
 |
In the Shadow of Polio: A Personal and Social History by Kathryn Black (Author) In 1954 Kathryn Black’s mother became one of the millions of people worldwide stricken with polio. A year later, as the Salk vaccine became widely available, the nation heaved a collective sigh of relief, and promptly buried its memories along with its dead.In the Shadow of Polio offers a penetrating look at this intense and significant period in American history. Black explores the lethal progression of her mother’s illness and its devastating emotional impact upon her family, interweaving her story with chapters that broaden into the social and historical context of the epidemic that randomly swept the nation in the 1940s and 1950s. Rich with anecdotes from Black’s years of interviews and correspondence, In the Shadow of Polio is a journey into the homes and hospitals, the lives... |
 |
In Search of the Polio Vaccine (History Channel) (A&E DVD Archives) Starring: Artist Not Provided |
 |
The Polio Paradox: What You Need to Know by Richard L. Bruno (Author) Polio is a disease of paradoxes, the major one being that although the threat of the "dreaded disease" ended with the Salk vaccine in 1954, many polio survivors are now experiencing the onset of Post-Polio Syndrome (PPS), new but related symptoms which may include chronic fatigue, muscle weakness, intolerance to cold, joint pain, and more. In his groundbreaking book, Dr. Bruno has sounded an alarming wake-up call for both doctors and PPS sufferers, including a large number who were originally misdiagnosed with something other than polio and can now pursue the medical help they need. By revealing how the physical and emotional treatment of polio in the past has exacerbated what we now call PPS today, THE POLIO PARADOX provides hope in the form of understanding and new treatment information... |
 |
Seven Wheelchairs: A Life beyond Polio by Gary Presley (Author) In 1959, seventeen-year-old Gary Presley was standing in line, wearing his favorite cowboy boots and waiting for his final inoculation of Salk vaccine. Seven days later, a bad headache caused him to skip basketball practice, tell his dad that he was too ill to feed the calves, and walk from barn to bed with shaky, dizzying steps. He never walked again. By the next day, burning with the fever of polio, he was fastened into the claustrophobic cocoon of the iron lung that would be his home for the next three months. Set among the hardscrabble world of the Missouri Ozarks, sizzling with sarcasm and acerbic wit, his memoir tells the story of his journey from the iron lung to life in a wheelchair. Presley is no wheelchair hero, no inspiring figure preaching patience and gratitude. An army brat... |
 |
Warm Springs: Traces of a Childhood at FDR's Polio Haven by Susan Richards Shreve (Author) Just after her eleventh birthday, Susan Richards Shreve was sent to the sanitarium at Warm Springs, Georgia. The polio haven, famously founded by FDR, was “a perfect setting in time and place and strangeness for a hospital of crippled children.” During Shreve’s two year stay, the Salk vaccine would be discovered, ensuring that she would be among the last Americans to have suffered childhood polio. At Warm Springs, Shreve found herself in a community of similarly afflicted children, and for the first time she was one of the gang. Away from her fiercely protective mother, she became a feisty troublemaker and an outspoken ringleader. Shreve experienced first love with a thirteen-year-old boy in a wheelchair. She navigated rocky friendships, religious questions, and family... |
| © 2009 BrightSurf.com |